Previous studies on TFDM also showed its stroke therapeutic effects mainly involve two aspects: first, activating the VEGF/tyrosine protein kinase SRC signaling pathway to promote angiogenesis; second, activating the PI3K/AKT signaling pathway to prevent cell apoptosis. Here, AKT1 is linked to stroke disorder.